-
Signature
-
/s/ James Pennington, Attorney-in-Fact
-
Issuer symbol
-
JANX
-
Transactions as of
-
14 Nov 2025
-
Net transactions value
-
-$64,694
-
Form type
-
4
-
Filing time
-
14 Nov 2025, 20:00:16 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Meyer Andrew Hollman |
Chief Business Officer |
C/O JANUX THERAPEUTICS, INC., 10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO |
/s/ James Pennington, Attorney-in-Fact |
14 Nov 2025 |
0001864159 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
JANX |
Common Stock |
Options Exercise |
$35,296 |
+3,333 |
+3.9% |
$10.59 |
88,307 |
14 Nov 2025 |
Direct |
F1 |
| transaction |
JANX |
Common Stock |
Sale |
$99,990 |
-3,333 |
-3.8% |
$30.00 |
84,974 |
14 Nov 2025 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
JANX |
Stock Option (right to buy) |
Options Exercise |
$0 |
-3,333 |
-2.7% |
$0.000000 |
118,101 |
14 Nov 2025 |
Common Stock |
3,333 |
$10.59 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: